Original Research
Published on 27 Sep 2024
Anisodamine (654-1/654-2) ameliorates septic kidney injury in rats by inhibiting inflammation and apoptosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1421551
- 500 views
Type at least 3 characters
562 articles
Articles
Original Research
Published on 19 Sep 2024
Guiding the starting dose of the once-daily formulation of tacrolimus in “de novo” adult renal transplant patients: a population approach
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1456565
- 522 views
Review
Published on 12 Sep 2024
Bibliometric and visual analysis of membranous nephropathy literature from 2010 to 2023
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426897
- 653 views
Original Research
Published on 10 Sep 2024
Individualized dosing parameters for tacrolimus in the presence of voriconazole: a real-world PopPK study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439232
- 615 views
Original Research
Published on 10 Sep 2024
Mitigative role of cysteamine against unilateral renal reperfusion injury in Wistar rats
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1456903
- 441 views
Original Research
Published on 09 Sep 2024
An investigation into the correlation between intraperitoneal teicoplanin concentrations and treatment outcomes in peritoneal dialysis-associated peritonitis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446774
- 524 views
Original Research
Published on 06 Sep 2024
Glomerular injury induced by vinyl carbamate in A/J inbred mice: a novel model of membranoproliferative glomerulonephritis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1462936
- 579 views
Systematic Review
Published on 04 Sep 2024
Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418826
- 752 views
Mini Review
Published on 04 Sep 2024
Endogenous bufadienolides, mineralocorticoid receptor antagonists and fibrosis in chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1431216
- 651 views
Review
Published on 04 Sep 2024
Zinc: a potential star for regulating peritoneal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1436864
- 729 views
Systematic Review
Published on 03 Sep 2024
Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1401939
- 1,339 views
Original Research
Published on 02 Sep 2024
Evaluating renal injury characteristics in different rat models of hyperuricemia and elucidating pathological molecular mechanisms via serum metabolomics
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433991
- 1,004 views
Original Research
Published on 28 Aug 2024
Development and validation of a nomogram to predict the risk of vancomycin-related acute kidney injury in critical care patients
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1389140
- 885 views
Systematic Review
Published on 26 Aug 2024
Efficacy and safety of oral sodium bicarbonate in kidney-transplant recipients and non-transplant patients with chronic kidney disease: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411933
- 928 views
Original Research
Published on 22 Aug 2024
Astragalus membranaceus and its monomers treat peritoneal fibrosis and related muscle atrophy through the AR/TGF-β1 pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418485
- 903 views
Review
Published on 21 Aug 2024
Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1394997
- 1,081 views